Document Detail

Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest.
MedLine Citation:
PMID:  17451196     Owner:  NLM     Status:  MEDLINE    
AIM: To investigate the growth inhibitory mechanism of NS-398, a selective cyclooxygenase-2 (COX-2) inhibitor, in two hepatocellular carcinoma (HCC) cell lines (HepG2 and Huh7).
METHODS: HepG2 and Huh7 cells were treated with NS-398. Its effects on cell viability, cell proliferation, cell cycles, and gene expression were respectively evaluated by water-soluble tetrazolium salt (WST-1) assay, 4'-6-diamidino-2-phenylindole (DAPI) staining, flow cytometer analysis, and Western blotting, with dimethyl sulfoxide (DMSO) as positive control.
RESULTS: NS-398 showed dose- and time-dependent growth-inhibitory effects on the two cell lines. Proliferating cell nuclear antigen (PCNA) expressions in HepG2 and Huh7 cells, particularly in Huh7 cells were inhibited in a time- and dose-independent manner. NS-398 caused cell cycle arrest in the G1 phase with cell accumulation in the sub-G1 phase in HepG2 and Huh7 cell lines. No evidence of apoptosis was observed in two cell lines.
CONCLUSION: NS-398 reduces cell proliferation by inducing cell cycle arrest in HepG2 and Huh7 cell lines, and COX-2 inhibitors may have potent chemoprevention effects on human hepatocellular carcinoma.
Ji Yeon Baek; Wonhee Hur; Jin Sang Wang; Si Hyun Bae; Seung Kew Yoon
Related Documents :
12000456 - Synchronous arabidopsis suspension cultures for analysis of cell-cycle gene activity.
8630336 - Early and late g2 arrest of cells undergoing radiation-induced apoptosis or micronuclea...
610886 - The histidine analogue l-histidinol arrests the growth of balb/3t3 cells in g0.
2022696 - Interactions of dimethyl sulfoxide and granulocyte-macrophage colony-stimulating factor...
23397796 - The karyomastigont as an evolutionary seme.
18401866 - Release of prostaglandin e(1) from n-(2-hydroxypropyl)methacrylamide copolymer conjugat...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  13     ISSN:  1007-9327     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-04-24     Completed Date:  2007-07-17     Revised Date:  2014-09-07    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  1175-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis / drug effects
Carcinoma, Hepatocellular / drug therapy*,  pathology
Cell Cycle / drug effects
Cell Line, Tumor
Cell Proliferation / drug effects*
Cell Survival / drug effects
Cyclooxygenase 2 / metabolism
Cyclooxygenase 2 Inhibitors / pharmacology,  therapeutic use*
Liver Neoplasms / drug therapy*,  pathology
Nitrobenzenes / pharmacology,  therapeutic use*
Sulfonamides / pharmacology,  therapeutic use*
Reg. No./Substance:
0/Cyclooxygenase 2 Inhibitors; 0/Nitrobenzenes; 0/Sulfonamides; 123653-11-2/N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide; EC 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells.
Next Document:  Assessment of hemodynamics in precancerous lesion of hepatocellular carcinoma: evaluation with MR pe...